DOTA-MGS5, a New Cholecystokinin-2 Receptor Targeting Peptide Analog With Optimized Targeting Profile for Theranostic Use

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.221283
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2017English

Stabilized, Cholecystokinin B Receptor (CCKBR; CCK2R)-targeting Radiopeptide for Tumor Imaging

Science-Business eXchange
2011English

Targeting Interleukin-4 Receptor With Hybrid Peptide for Effective Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Theranostic Nanoparticles Loaded With Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2017English

Targeting Angiogenesis With Peptide Vaccines

Frontiers in Immunology
AllergyImmunology
2019English

[(Cp-R)m(co)3] (M= Re or 99mTc) Conjugates for Theranostic Receptor Targeting

Chimia
MedicineChemistry
2013English

Evaluation of DOTA-chelated Neurotensin Analogs With Spacer-Enhanced Biological Performance for Neurotensin-Receptor-1-Positive Tumor Targeting

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2015English

Targeting Liver Fibrosis With a Cell-Penetrating Protease-Activated Receptor-2 (PAR2) Pepducin

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy